FindTrial
Sign In

A prospective study of doses to the normal tissues and the tumor in helical tomotherapy technique versus intensity modulated radiation therapy technique for patients with head and neck cancer

"A PROSPECTIVE DOSIMETRIC STUDY OF HELICAL TOMOTHERAPY VERSUS INTENSITY-MODULATED RADIATION THERAPY FOR PATIENTS WITH HEAD AND NECK CANCER" - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/077805
Enrollment
49
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Sponsors

Dr Kartikay Goel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years and less than 70 years Histologically proven squamous cell carcinoma of head and neck Oral cavity, oropharynx, hypopharynx, nasopharynx, supraglottic larynx Head and neck cancer patients having standard indication of radiation therapy Non metastatic

Exclusion criteria

Exclusion criteria: Prior radiotherapy to head and neck Recurrent disease

Design outcomes

Primary

MeasureTime frame
To evaluate the dose received by Planning Target Volume (PTV) and Organs At Risk (OAR) during intensity-modulated radiation therapy and helical tomotherapy in patients with head and neck cancerTimepoint: The dose evaluation will be done at baseline—

Secondary

MeasureTime frame
To evaluate the doses to OARS & which one is better IMRT or HT.Timepoint: AT baseline—

Countries

India

Contacts

Public ContactDr Rashi Agrawal

Max Super Specialty Hospital

drrashi.ag@gmail.com9891483550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026